Login   |  Users Online: 995 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
  
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts
This article has been cited by
1Withania somnifera as a potential candidate to ameliorate high fat diet-induced anxiety and neuroinflammation
Taranjeet Kaur,Gurcharan Kaur
Journal of Neuroinflammation.2017;14(1)
[DOI]
2Effects of Ashwagandha (Withania somnifera) on VO2max: A Systematic Review and Meta-Analysis
Jorge Pérez-Gómez,Santos Villafaina,José Carmelo Adsuar,Eugenio Merellano-Navarro,Daniel Collado-Mateo
Nutrients.2020;12(4)1119
[DOI]
3Effects of Ashwagandha (Withania somnifera) on VO2max: A Systematic Review and Meta-Analysis
Vikas Kumar,Amitabha Dey,Shyam Sunder Chatterjee
Nutrients.2017;12(4)37
[DOI]
4Effects of Ashwagandha (Withania somnifera) on VO2max: A Systematic Review and Meta-Analysis
Gurcharan Kaur,Taranjeet Kaur,Muskan Gupta,Shaffi Manchanda
Nutrients.2017;12(4)417
[DOI]
5Metabolomic and biotechnological approaches to determine therapeutic potential of Withania somnifera (L.) Dunal: A review
Niraj Tripathi,Divya Shrivastava,Bilal Ahmad Mir,Shailesh Kumar,Sumit Govil,Maryam Vahedi,Prakash S Bisen
Phytomedicine.2018;50(4)127
[DOI]
6Metabolomic and biotechnological approaches to determine therapeutic potential of Withania somnifera (L.) Dunal: A review
Shri K. Mishra,Bharathi A. Venkatachalapathy,Hadi M. Khanli
Phytomedicine.2017;50(4)313
[DOI]
7Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects
Deepa S. Mandlik (Ingawale),Ajay G. Namdeo
Journal of Dietary Supplements.2020;50(4)1
[DOI]
  Feedback 
  Subscribe